BioNote, Inc. (KRX:377740)
4,700.00
+5.00 (0.11%)
At close: Oct 2, 2026
| Market Cap | 474.29B -19.3% |
| Revenue (ttm) | 126.41B +12.8% |
| Net Income | -125.69B |
| EPS | -1,246.93 |
| Shares Out | 100.91M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 228.00 (4.85%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 28,645 |
| Open | 4,695.00 |
| Previous Close | 4,695.00 |
| Day's Range | 4,640.00 - 4,720.00 |
| 52-Week Range | 4,050.00 - 6,260.00 |
| Beta | 0.63 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |